CBLL (ceribell.com) Net Income

Official company branding of ceribell.com (CBLL)

The market value dynamics of CeriBell, Inc. (CBLL) on the GURU.Markets platform stand at -0.07. The company's business is based on creating advanced tools for brain function analysis. The compactness of the systems simplifies their transport and reduces supply costs for clinics. The gradual integration of these technologies into medical networks creates a stable cash flow through the sale of replacement sensors, confirming sustainable growth.

Company Net Income: CeriBell EEG (CBLL) for 10/12/2024 - 10/29/2026

Financial and market metric breakdowns for CeriBell (CBLL)

- stock value and consensus price forecast:
Market Price CeriBell EEG|CBLL - Analyst Consensus Forecast
- business market valuation indicators:
Market Valuation CeriBell EEG|CBLL - Enterprise Value
- company book value details:
Net Asset Value per Share CeriBell|CBLL - Company Book Value|Market Value to Book Value ceribell.com|CBLL - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient CeriBell, Inc.|CBLL - Long-Term Debt to Capital|Short-Term Debt to Equity CeriBell Inc|CBLL - Company Aggregate Debts|Debts to Book Value CeriBell EEG|CBLL - Company Long-Term Debt|Company Short-Term Debt CeriBell|Quick Liquidity ceribell.com
- company profitability and valuation multiples indicators:
CBLL - Net Income
Fundamental valuation:CBLL CeriBell EEG
Mass-produced product of CeriBell Inc

Investors assess the operational strength of an asset through its ability to generate real cash flow. For CeriBell, Inc. (CBLL), this process depends directly on the efficiency of rapid-EEG system implementation and the retention of R&D personnel. This net profit chart reflects the daily equity value of revenues, net of operating expenses. This indicator measures the actual business efficiency in real-time. A stable trajectory confirms the company's financial resilience during expansion.

Main competitors

Company Net Income Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Net Profit|Net Income regencellbioscience.com (RGC)|Net Profit AXSM|ACAD - Company Net Income|Company Net Income Xenon Pharmaceuticals Inc XENE|Final Profit VKTX|Supernus Pharmaceuticals - Net Profit|Net Financial Result catalystpharma.com CPRX|DNLI: Net Profit|HRMY (Harmony Biosciences Inc) - Company Net Income|BHVN (Biohaven Pharmaceutical) - Net Profit|Company Net Income Amylyx Corp AMLX|Company Net Income Trevi Therapeutics (TRVI)|Company Net Income PRAX (praxismedicines.com)|Company Net Income Anavex Life Sciences Corp. AVXL|Prothena Corp - Company Net Income|ALEC: Net Income|Final Profit ANNX (Annexon Biosciences Inc.)|OMER: Net Profit|NGNE - Net Financial Result|Company Net Income AC Immune SA|Company Profit VYGR (Voyager Therapeutics Inc)|Net Profit NMRA|Net Income Scilex Holding Company, Inc. SCLX|Tevogen Bio Holdings - Net Income|Net Financial Result Alpha Cognition Inc (ACOG)|Cognition Therapeutics - Net Profit|Inhibikase Therapeutics Inc (IKT) - Net Income|SAVA: Net Profit|ASRT (Assertio) - Company Net Income|Company Net Income Coya Therapeutics Inc|Company Net Income VTGN|Company Net Income Ovid Therapeutics Inc. (OVID)|Company Net Income ABOS (Acumen Pharmaceuticals Inc.)|Company Net Income CervoMed Inc CRVO|ATHE: Company Profit|Clene Nanomedicine - Net Profit|Company Net Income PepGen Inc.|JUNS (Jupiter Neurosciences Inc) - Net Income|Relmada Therapeutics Inc (RLMD) - Net Profit|Company Net Income Annovis Bio Corp|GRCE: Final Profit|Company Net Income Firefly Neuroscience, Inc (AIFF)|KLTO - Company Net Income|Net Profit NRSN (NeuroSense Therapeutics Ltd.)|RVPH - Net Income|MetaVia, Inc. - Net Profit|Company Net Income NeurAxis Inc|heliusmedical.com (HSDT) - Company Net Income|Passage Bio - Final Profit|NEUP (Neuphoria Therapeutics, Inc.) - Net Profit|Minerva Neurosciences Inc (NERV) - Net Financial Result|Net Profit ATHA|Company Net Income ADXN (Addex)|Net Profit ALZN (Alzamend Neuro)|Cyclerion Therapeutics Inc. (CYCN) - Company Net Income|PTIX - Company Net Income|KTTA: Company Net Income|cortigent.com (CRGT) - Company Net Income|ATXI (Avenue Therapeutics Inc) - Company Net Income|Net Income BCLI|CARA: Final Profit|Net Profit CHRO|Net Financial Result eliemtx.com|Company Net Income Intra-Cellular Therapies, Inc. ITCI|LBPH: Company Profit|Marinus Pharmaceuticals - Net Profit|nkgenbiotech.com (NKGN) - Net Income|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net Income|SAGE - Net Financial Result|SNPX (Neurotrope) - Net Profit|Net Income Trevena Inc (TRVN)|Net Profit VIGL|Company Net Income WENA (Anew Medical Inc.)|Company Net Income Cerevel Therapeutics, Inc. CERE